1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsEpilepsy Medication Assistance Program is sponsored by Florida Department of Health. This program provides epilepsy medication to eligible Florida residents who are uninsured, lack adequate insurance coverage for epilepsy medication, or have unaffordable deductibles/co-pays. It's a safety net program to ensure access to necessary medications.
Get alerted about grants like this
Get emailed when new opportunities from “Florida Department of Health” or related funders appear. Free, weekly, unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Epilepsy Medication Assistance - Florida Department of Health The Epilepsy Medication Assistance Program is a safety net program that provides epilepsy medication to individuals when they need assistance paying for it.
Brand name medication will only be issued when the client provides a statement from the prescriber that includes the following: Brand name medication is medically necessary Use of the generic version of the medication was attempted by the patient and was not effective Use of the generic version of the medication has not been attempted due to the severity of the patient’s epilepsy To qualify for the program, applicants must meet the following criteria: Be a self-declared resident of Florida Uninsured, lacking insurance that covers epilepsy medication, or an insurance deductible or co-pay that the applicant is not able to afford Net family income at or below 100% of the federal poverty guidelines No more than $2,500 in private funds, bank accounts, or assets, other than a homestead Not a current Medicaid recipient To enroll into the Epilepsy Medication Assistance Program, complete the Epilepsy Services Medication Assistance Program Application .
Once completed, submit the application, recent prescription for epilepsy medication, physician statement (if applicable), and proof of: Insurance (if applicable) In the event the county health department does not have a licensed pharmacy on site, the prescription will be sent to the Bureau of Public Health Pharmacy to be filled. The client will receive the prescription through certified mail – signature is required for delivery.
To get prescriptions filled as a member of the Epilepsy Medication Assistance Program, the client must bring a recent prescription to a county health department or complete the online refill home delivery form . Chronic Disease Prevention
According to the current listing, eligibility includes: Self-declared Florida residents who are uninsured, lack insurance that covers epilepsy medication, or have an insurance deductible or co-pay that the applicant is not able to afford. Confirm the full requirements in the official notice before applying.
Epilepsy Medication Assistance Program is funded by Florida Department of Health. Verify program details on the funder's official page before applying.
This opportunity targets applicants in Florida. If your organization operates elsewhere, check the official notice for location requirements.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
NCI Continuing Umbrella of Research Experiences (CURE) Academic Career Excellence (ACE) Award (K32) is a grant from the National Cancer Institute (NCI) that funds early postdoctoral fellows from diverse backgrounds, including underrepresented groups, to pursue research training in cancer-related fields. The K32 award supports fellows within 12 months prior to transitioning into, or within the first two years of, a postdoctoral position. The program, operated through NCI's Center to Reduce Cancer Health Disparities (CRCHD), aims to enhance the pool of qualified diverse cancer researchers. Beginning with the June 12, 2025 due date, the CURE ACE Award is available in both Independent Clinical Trial Required and Independent Clinical Trial Not Allowed versions. Eligible applicants must be U.S. citizens or permanent residents at time of award.
Smart Health and Biomedical Research in the Era of Artificial Intelligence and Advanced Data Science (SCH) is sponsored by National Science Foundation (NSF) & National Institutes of Health (NIH). This interagency program supports high-risk, high-reward advances in AI and data science for biomedical and public health research. Projects must cross disciplinary boundaries.
RWJF's Health Equity Research for Action puts up ~20 grants of up to $500,000 — but demands a two-year community partnership and a community co-PI. Here's the strategy, set against the brightest foundation-giving outlook since 2022.
Read articleCMS awarded all 50 states a slice of the $50 billion Rural Health Transformation Program on December 29, 2025 — first-year checks average $200M, ranging from $147M to $281M. The federal application is closed and you cannot apply to CMS. The money reaches hospitals, clinics, and nonprofits only as state subawards, and those competitions open through 2026. Here is how the formula worked, what the funds can and cannot buy, and how to position for a subaward before the money starts flowing.
Read articleCMS awarded the entire $50 billion Rural Health Transformation Program to all 50 states, with first-year checks averaging $200M per state and money starting to move October 1, 2026. The federal contest is over — but for rural hospitals, clinics, behavioral-health providers, and nonprofits, the real competition is just beginning inside each state's sub-grant process. Here is how the money splits, what it can fund, and how to position now.
Read article